ESB
REGN icon

Essex Savings Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Essex Savings Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-282
Closed -$218K – 328
2026
Q1 		$218K Buy
282
+6
+2% +$4.59K 0.05% 287
2025
Q4 		$213K Buy
+276
New +$187K 0.05% 299

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Essex Savings Bank's REGN Position: Q2 2026 in Review

Essex Savings Bank sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 282 shares — an estimated $218K sold.

Essex Savings Bank first reported a position in REGN in Q4 2025 and held it in 2 quarters. The position peaked at $218K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Essex Savings Bank reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Essex Savings Bank sold 282 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $218K.
  • Essex Savings Bank first reported a position in Regeneron Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Essex Savings Bank's Regeneron Pharmaceuticals position peaked at $218K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.